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Abstract
Hypertension (HT) is one of the major diseases associated with the circulatory system
and remains a public health problem with a high rate of prevalence in the adult
population in the USA. The pressure natriuresis mechanism which is Na+ excretion in
respond to rise in blood pressure acts as a long-term regulator of arterial blood
pressure. Recent studies have demonstrated that impairment of this long-term pressure
natriuresis mechanism is involved in hypertension (HT) and many other renal disorders.
Exercise is a nonpharmacological treatment to help control HT, and exercise has a
beneficial effect on vascular health, endothelial functions, arterial stiffness, blood
pressure, and VO₂ max (49). Since exercise is beneficial to hypertensive patients, it is
important to understand the relationship between exercise and pressure natriuresis. The
goal of this study was to determine if voluntary exercise in young spontaneously
hypertensive female and male rats altered pressure natriuresis. Forty 4-week-old SHR
(Twenty female and Twenty male) were randomly assigned into two treatment groups,
exercise and sedentary. After 8 weeks, urine was collected during baseline, lowered,
and raised renal perfusion pressures (RPPs). Urinary Na excretion was measured and
pressure natriuresis curves (Na+ excretion vs RPP) were generated for each group.
Exercise in female spontaneously hypertensive rats( SHRs) significantly improved the
pressure natriuresis relationship, with the exercised female rats producing a greater
increase in sodium excretion for any given increase in RPP. However, exercise in the
males had no significant effect on the pressure natriuresis relationship. This study
suggests that sex differences may play an important role in long-term pressure
regulation and exercise performance in SHRs. Further understanding of the
mechanisms behind this beneficial effect of exercise on pressure natriuresis may
support the development of new therapeutics for hypertension.

1

Introduction

Hypertension and Prevalence
Hypertension is one of the most common disorders associated with the circulatory
system and remains a major public health problem, with a high rate of prevalence in the
adult population in the USA. Hypertension (HT) is defined as a chronic or temporary
elevation of arterial blood pressure (59). Arterial pressure can be divided into systolic
and diastolic pressure. Systolic pressure occurs as blood is pumped out of the heart
through the aorta and pulmonary trunks. Diastolic pressure occurs as the heart rests
between heartbeats, and these pressures are elevated in HT patients (59).
Hypertension affects more than 1.2 billion individuals worldwide, and the 2017 medical
guidelines showed that 81.9 million people depend on antihypertensive medication,
while non-pharmacological interventions were recommended for only 9.4% of
hypertensive patients (47). Patients with hypertension usually have several factors that
can affect the results of research, including drug therapies, daily living activities, and
level of stress, which makes it difficult to perform well-controlled long-term studies in
human beings (77). Animal models with hypertension, such as rodents, are suitable
models for study because researchers can control their diet, drugs and activity (77). The
developmental period of hypertension is very short in spontaneously hypertensive rats
(SHRs) when compared to humans. SHRs develop hypertension beginning at 7 weeks
of age, with rapidly increasing BP with aging (77).So rat models are great model
organism for study hypertension.

2

Health Impacts and Risk Factors
Hypertensive patients have an increased risk of stroke, heart failure, renal dysfunction,
and other health-related problems (10, 54). Hypertension also increases the mortality
rate of cardiovascular disease (47) and causes severe functional and structural
damages to the brain, which can lead to vascular dementia (10). HT can occur due to
hereditary and environmental factors. Environmental factors include too much salt
intake, drinking too much alcohol, smoking, less potassium intake, stress and obesity,
sedentary lifestyle, and many chronic conditions such as renal dysfunction (2, 40,44).
Among environmental factors, high salt intake and high Na+ concentration in the blood
is a major risk factor of getting HT. A high salt diet may induce changes in the vessel
walls. High salt induce diet may also lead to alterations in collagen accumulation and
increased vascular stiffness (30,68). High renal fibrosis is also observed in
hypertensive subjects, however, it becomes less severe with daily exercise or aerobic
training (20). Vascular structural changes, endothelial dysfunctions, renal dysfunctions,
and sympathetic overstimulation (35) are major factors that lead to the pathophysiology
of hypertension. Artery stiffness is also a significant risk factor in hypertension and other
cardiovascular diseases (7). Other behavioral and environmental factors are also
related to blood pressure. People who migrate from underdeveloped to developed areas
often have increased blood pressure due to changes in nutrition, exercise activity, and
stress (51).
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Epidemiology - Sex Difference
Gender is one of the main risk factor and both men and women are prone to
hypertension. Men are more prone to hypertension and other renal diseases than agematched women (12,60,64). However, studies by Pinto et. al. demonstrated that the risk
of hypertension increased with age for both sexes (60). Sex differences in hypertension
are based on physiological factors due to aging, sex hormones, other disease
conditions, and behavioral factors (4,67,60,12,51,45).
Aging is one of the main risk factors associate with hypertension. Compared to young
individuals, elderly people have an increased risk of cardiovascular diseases (CVD) and
renal inflammation due to physiological changes in their bodies. The systolic blood
pressure (SBP) rises steadily, however diastolic blood pressure (DBP) increases to a
maximum level and becomes plateaued or decreases with aging (60). The Framingham
heart study reported that SBP was raised between the ages of 30-84 and DBP
decreased between the ages of 60-84. (60,69).
Sex differences in hypertension are also associated with age. The rise in systolic
pressure is steeper in women compared to age-matched men (60,17). A 25-year
observational study in Sweden reported that (67 years ) women had a higher average
blood pressure than younger women, whether they were hypertensive or not. However,
hypertension in men produced a greater increase in mortality risk compared to sameaged women (48). Young men are more prone to CVD and renal diseases than agematched women (60,12,21). One study found that among 18-29-year-old white
adults,1.5%of women versus 5% percent of men have hypertension (21). The death
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rates were doubled among hypertensive middle-aged men compared with middle-aged
women. Hypertension is more common in middle-aged men than women (4). The
National Health and Nutrition Examination Surveys (NHANES III) have shown that
normotensive and hypertensive young men have higher overall mean arterial pressure
than women (13,56). Young women have fewer stiff arteries compared with same-aged
men (68). Although an increase in artery stiffness occurs after menopause in women,
rates always remain lower than in men (9,71,60,68). Higher levels of blood pressure in
men compared to women increase the incidence of stroke, heart failure, and renal
dysfunctions in men. Coronary artery diseases also develop in younger aged men
compare to women (4). Moreover, high-density lipoprotein levels are lower in men
(63,5) and this increases the risk of hypertension, coronary heart disease, stroke, heart
failure, and renal disease. High-density lipoproteins lower the risk of hypertension and
other CVD such as atherosclerosis.
The female sex hormone, estrogen, has a cardiac protective effect, and estrogen
modulates vascular endothelial functions (33). A study by Beckhoff et. al. found that
ovariectomized female SHR had an increased risk of hypertension (4,19). Reckelhoff et.
al. demonstrated that testosterone injected into the spontaneously hypertensive rat
results in a hypertensive shift in the pressure regulation (4,19).
Some forms of hypertension are more common in women. Hypertension occurs more
often in type II diabetic women than men (60,17). ISH (Isolated systolic hypertension) is
a form of hypertension that results in a diastolic blood pressure less than 80 mmHg, but
a systolic blood pressure higher than 130 mmHg (60). The Framingham heart study
found a higher prevalence of ISH in older women than in older men (60). This is due to

5

stiffer arteries with a wider radius or other physiological and behavioral factors.
However, the higher total amount of activity and weekly vigorous activity had an inverse
association with hypertension in women (5).
Lifestyle-related risk factors also vary between the sexes. According to a study by
Bethany et. al. 35% of women and 29 % of men have a healthy weight (9). This might
be due to a healthy diet and healthy living (9). The smoking percentage was increased
in men compared to women. However, women have lower levels of physical activity
compared to men (36% of women and 46% of men participate in regular physical
activity) (9). Studies also reported that women have more awareness of hypertension
and are more likely to report their normotensive or hypertensive BP than men. Women
have more recent doctor visits compare to men. 46% of women have seen a medical
professional recently compared to 30% of men (9). These factors can contribute to the
sex difference in hypertension and other cardiovascular diseases. Although both men
and women suffer from CVD later in their life, (5,72,21) there was a preventive effect of
leisure-time physical activity on coronary artery disease, and hypertension, regardless
of the degree of overweight or obesity (32,18,34).

Mean Atrial Pressure (MAP)
The blood pressure reading is usually marked as the systolic number over the diastolic
number. Blood pressure in normotensive individuals is around 120mmHg over
80mmHg. A hypertensive patient will have high systolic blood pressure
(SBP>140mmHg) and/or high diastolic blood pressure (DBP>90mmHg) (59). Mean
arterial pressure (MAP) is the average arterial pressure over a single cardiac cycle
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- systole, and diastole (22). MAP is influenced by cardiac output (CO) and vascular
resistance (VR). Cardiac output is measured as the product of heart rate (HR)
and stroke volume(SV)(22). Increased blood volume will increase the ventricular filling
volume, (preload), the SV, and therefore increase CO and MAP (22) Systemic vascular
resistance is primarily determined by the diameter of the blood arterioles. Decreasing
the diameter of an arteriole increases vascular resistance because blood must pass
through a smaller radius vessel. Short-term regulation of MAP is under baroreceptor
reflex control, which uses the autonomic nervous system to affect both cardiac output
and systemic vascular resistance to maintain MAP within the proper range (22). Longterm regulation is believed to be under the control of the renal system through blood
volume regulation, which directly affects cardiac output (22).

Renal Pressure Natriuresis
Arthur Guyton was the first to identify the role of the renal pressure mechanism in mean
arterial pressure control (54). Pressure natriuresis is a major control mechanism for the
regulation of body fluid volume and long-term arterial pressure or mean arterial pressure
(54). The kidneys increase Na+ elimination when blood pressure is elevated to
decrease blood volume, which decreases end-diastolic volume (EDV), stroke volume
(SV), and CO (59). This eventually decreases MAP. Elevations of blood pressure at the
kidney initiate decreased reabsorption of sodium and water by the renal tubules, and
this results in a high Na+ concentration in the urine (natriuresis)(54). Dysfunction of this
mechanism leads to numerous cardiovascular and renal diseases, including
hypertension (54). The SHRs are a suitable model for examining changes in pressure
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natriuresis because the SHR’s renal pressure natriuresis mechanism is similar to that of
humans, and SHR also develop hypertension as they age.

Hormone Regulation- RAAS
The main hormone system for the regulation of intravascular volume and systemic
blood pressure is the renin-angiotensin-aldosterone system (RAAS)(35). This RAAS
cascade influences the kidney, lungs, vasculature, and brain (37). This system affects
vascular tone, sodium retention, oxidative stress, fibrosis, sympathetic tone, and
inflammation (23). The RAAS is responsible for chronic alterations in blood pressure
(37). Both kidneys secrete the enzyme renin, and this is the very first step of the RAAS
cascade. Renin converts angiotensinogen to angiotensin I. Angiotensin I is quickly
converted to angiotensin II by angiotensin-converting enzyme (ACE) located on the lung
vascular endothelium (23,16). Angiotensin II (Ang II) binds to two major receptors, type
1 (AT1) and type 2 (AT2) receptors (58). AT1R enhances anti-natriuresis and raises BP,
AT2R has the opposite effect of AT1R. AT2R enhances the natriuretic response and
reduces blood pressure (15). RAAS activity is essential for long-term blood pressure
regulation, same as the pressure natriuresis. However, RAAS is also responsible for
elevated blood pressure in certain conditions. More importantly, RAAS blocking drugs
have been available and commonly used in today’s medical world. Overstimulation of
RAAS can contribute to many CVDs and renal dysfunctions. Inhibition of ACE or renin
concentrations can inhibit the RAAS cascade. The overall goal of inhibition of the RAA
activity is to improve renal output and reduce cardiovascular mortality rates (23,16). The
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RAAS cascade is affected by sex hormones, however, both sexes utilize the same
antihypertensive drugs (73,24).
Ang II has major effects on the kidney, adrenal gland, arterioles, and brain (37).
Angiotensin II (Ang II) causes increased blood pressure by raising vascular resistance
through direct vascular constriction. In addition, Ang II also stimulates extracellular
protein synthesis by boosting the signaling activity (38), which may lead to renal fibrosis.
High renal fibrosis is one of the risk factors for elevated blood pressure (35). The RAAS
stimulates the synthesis of pro-inflammatory molecules and pro-fibrotic agents that
contribute to altering the function of some organs during certain disease conditions. In
rodents, ANG II blocking agents protect against neurodegeneration and promote
longevity (8). Angiotensin receptor blockers are used to decrease pre-hypertension (55)
However decreased levels of Ang II also decrease arterial resistance, which lowers
systolic and diastolic blood pressure (20).
Although the RAAS serves as a long-term blood pressure regulator, the RAAS can be
activated or overstimulated due to several conditions that lead to the development of
HT. Overexpression of plasma renin (PRA) and aldosterone (ALDO) is common in
obese and hypertensive people, and these increase blood volume and vascular
resistance. High levels of ALDO have been associated with increased aortic and arterial
stiffness which increases the systolic and diastolic blood pressures (20). In obese
individuals, elevated plasma renin, angiotensin, and aldosterone levels cause
vasoconstriction, and this may lead to high blood pressure (20). The RAAS also is
involved in the SHR’s pathophysiology of renovascular hypertension. Aldo causes an
increase in sodium reabsorption and potassium excretion at the distal tubule and
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collecting duct of the nephron (16). Aldosterone stimulates the insertion of the Na+
channel/ basolateral Na-K ATPase protein (37). An increase in Na+ in the body leads to
an increase in osmolarity and an increase in blood and extracellular fluid. This will
increase blood pressure due to the large blood volume (37). Ang II also acts on the
brain which stimulates thirst and the release of anti-diuretic hormone (ADH). ADH acts
to increases water reabsorption in the kidney (16,37).

Natriuretic Peptides
There are 3 major natriuretic peptides found in the human body. Atrial natriuretic
peptide (ANP), brain natriuretic peptide ( b-type) (BNP), and urodilatin (27,31,53,62).
These peptides play an important role in intravascular blood volume and vascular tone
regulation (53). ANP is primarily stored in atrial granules and becomes a mature peptide
inside the circulatory system. BNP is stored in atrial granules and ventricles, and it was
first found in the brain tissue (61). The kidneys produce and secrete a compound
similar to ANP, called urodilatin (31,61,62). Urodilatin, first discovered in urine, is related
to the ANP family and is involved with the regulation of natriuresis (61). Fielder et al
studied urodilatin concentrations in intact and cardiac denervated dogs. This study
found that urodilatin is primarily involved with renal Na+ regulation and has a closer
relation to Na+ excretion than circulating ANP (27,31, 39, 31). The study also indicated
that natriuretic peptides attenuate sympathetic nerves and contribute to hormone
regulation (39). Unlike other types of ANP, urodilatin does not circulate in the blood
(27,31). Natriuretic peptides are involved in the communication that occurs between
cardiovascular and metabolic diseases, such as between hypertension and diabetes
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(39). Urodilatin is used as a diagnostic tool for CVD and heart failure (75). Natriuretic
peptide-mediated therapeutics are an important treatment for patients suffering from
metabolic diseases and CVDs. Administration of ANP and ANP antagonists has
demonstrated that ANP has antihypertrophic and antifibrotic functions. In some in vitro
studies, rodents lacking natriuretic receptor-A (NPR-A) developed cardiac hypertrophy
and fibrosis (53). Nishikimi et al found that ANP and BNP have a cardiac protective
function (53).

Hypertension Treatments- Pharmacological
Prescribed antihypertensive drugs are very common in the medical world. Treatments
for HT in stage 1 and stage 2 are mainly based on antihypertensive drugs. Treatments
are individualized for patients who are suffering from other CVD, renal disease, or
diabetes (57). The treatments also depend on the stages of hypertension and age (57).
According to the American Heart Society (AHS) and the American College of Cardiology
(ACC), for stage 1 HT, the systolic range remained between 130-139, or the diastolic
BP range remained between 80-89. Stage 2 HT patients have systolic BP over 140 and
diastolic over 90 (57). Target blood pressure is changed if other diseases conditions are
present (3). For example, in patients with chronic kidney disease and diabetes, the
target blood pressure will be 130/80 (3).
Some common antihypertensive drugs are Thiazide -type diuretics, calcium channel
blockers, ACE inhibitors and angiotensin 2 receptor blockers (ARBs). Thiazide diuretics,
such as chlorthalidone and Indapamide, are a primary treatment for HT for all ages
(3,26,25,57). Calcium channel blockers have been shown to reduce cardiovascular
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mortality rates (57,76). These can be used as an alternative to diuretics (76). Some of
the Ca++ channel blockers act as vasodilators (57,76,14). Ace inhibitors have shown
effective cardiac protection for patients with kidney diseases and proteinuria. Ramipril is
one of the most common ace inhibitors (76, 29). Beta-blockers are another
antihypertensive drug. However, this drug has fewer protective effects in older patients
(42).
Antihypertensive drug therapies are not always successful in patients with underlying
disease conditions. Diabetic patients have a high risk of getting hypertension because
of altered carbohydrate metabolism (46). ACE inhibitors, angiotensin (types 1(AT1))
receptor blockers (ARBs), and calcium channel blockers are not always used to treat
hypertensive patients with diabetes because antihypertensive drug usage is associated
with harmful side effects. Conditions such as hyperkalemia are increased in patients
with renal abnormalities, heart failure, and diabetes (57,46). Many hypertensive patients
with diabetes require combined antihypertensive drug therapy to lower blood pressure
(46, 43). Researchers observed that most drugs improved endothelial dysfunction.
However, some drugs also improve plasma adiponectin and leptin levels as well
Adiponectin has cardioprotective functions (43). Leptin is directly associated with
adipose tissue and causes several cardiovascular complications. Plasma leptin levels
are mainly responsible for stimulating vascular inflammation, oxidative stress, and
vascular smooth muscle hypertrophy (43). Leptin levels might responsible for diseases
such as atherosclerosis, which is a major risk factor associate with hypertension. On the
other hand, there were many complications associate with these drugs. Because of the
excessive usage of anti-hypertensive drugs, side effects, and complexity of the drug
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therapy, medical professionals have attempted to find alternative treatments (57,46).
Minimal costs and side effects were associated with drug-free exercise training (50).

Exercise and Cardiovascular Physiology
Health professionals, ACC, and AHS also recommend lifestyle modifications such as
daily exercise, for elevated blood pressure (57, 3,40). The American College of Sports
Medicine (ACSM) found that at least 30 minutes of dynamic aerobic endurance exercise
and resistance exercise per day helped to reduce elevated blood pressure in humans
(1,40). Aerobic and regular physical activity reduces the risk of getting hypertension and
other cardiovascular diseases. Studies also found that eight weeks of resistance or
endurance training similarly reduce pre-hypertensive blood pressure and improved
endothelial function in pre-hypertensive patients (6). There are different exercise
training strategies and different types of exercise that help to reduce arterial pressure.
Human studies have shown that exercise reduces systolic, diastolic, and mean arterial
pressure (28,40). Exercise training sessions enhance endothelial function and decrease
systolic and diastolic blood pressure by approximately 8-17 mmHg and 6-13 mmHg,
respectively (1,6). Resistance exercise leads to a reduction of resting SBP and DBP
which reduces systemic and pulmonary blood pressure (6).
In addition to lowering blood pressure, these studies found that aerobic training
decreased central pulse wave velocity (PWV) and plasma aldosterone (Aldo) levels.
Aerobic training in obese hypertensives has decreased plasma Aldo level and it was
significantly correlated with PWV reduction(20). Increased Plasma Aldo level can
stimulate RAAs and increase Na reabsorption which results in hypertension. PWV is
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used to measure an individual’s arterial stiffness. Increase plasma aldosterone
concentrations lead to greater PWV in hypertensive adults. An increase in blood
pressure causes the vascular tone to increase. Exercise increases sympathetic activity,
which results in increased cardiac output and an increased blood flow to the lungs (49).
A recent study investigated the effect of resistance and aerobic exercise on central
blood pressure and myocardial oxygen use in hypertensive and pre-hypertensive
patients. The study found that exercise training reduces peripheral arterial stiffness and
myocardial oxygen demand (7). Physical activity can increase blood flow to the kidneys,
reduce urinary proteins, reduce renal inflammation, and inhibit fibrogenesis of the
kidney (20,35). Exercise reduces cardiovascular risk factors by decreasing blood
pressure, improving lipid values, and reducing oxidative stress (35).
It is clear that exercise training is beneficial to hypertensive patients, however, the exact
physiological mechanism by which exercise is beneficial is unclear. Some studies
supported that the effects of exercise training are due to reduced sympathetic activity
and improved autonomic functions (77). Other studies suggest that exercise training is
associated with neuronal plasticity in the brain area that regulates blood pressure (77).
Moreover, exercise training reduces renal fibrosis in SHR and helps to prevent kidney
damage (35). These studies found differences in the pathophysiology of kidney sections
in SHR-sedentary and SHR-exercised groups, showing that renal fibrosis was
significantly different between the SHR exercise and sedentary groups (35).
It is crucial for the understanding of hypertension to investigate the physiological
mechanisms underlying this disease and the mechanisms by which exercise can
mitigate these effects. Exercise training can reduce visceral fat and improve Na+
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elimination by altering renal function. Exercise training increased blood flow to the renal
interstitial which stimulates the pressure natriuresis mechanism. Furthermore,
elevations of blood pressure at the kidney also initiate decreased reabsorption of
sodium in renal tubules, and high Na+ concentration in the urine (54). Exercise also
alters kidney filtration by improving capillary hydrostatic pressure and increasing fluid
exit into the renal interstitium. This results in greater Na+ excretion. Moreover, physical
activity improves kidney functions, glomerular filtration capacity and contributes to
improve Na+ excretion in normotensive and hypertensive subjects. Most studies on
exercise and hypertension focus on aerobic exercise such as walking, running,
swimming, and cycling (28).

This Study
Regular exercise has been reported to have benefits for the SHRs such as decreased
blood pressure, reduced oxidative stress, reduced renal inflammation, and reduced
fibrogenesis. However, the mechanisms for the decrease in blood pressure are not
clear. A previous study in this lab found that voluntary exercise improved pressure
natriuresis in a normotensive rat (WKY). Therefore, this study was designed to
investigate the effects of voluntary exercise on pressure natriuresis in a hypertensive
rat, the spontaneously hypertensive rat (SHR) (35). I hypothesized that exercise training
will improve the pressure-natriuresis relationship (increase urinary sodium excretion
with increases in renal perfusion pressure) in exercised female and male SHR rats.
Exercised rats who allowed to exercise for 8-9 weeks will excrete more sodium for any
increase in blood pressure than sedentary rats (not allowed to exercise).
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Methods

Exercise Protocol:
Twenty female SHR and twenty male SHR from our colony were weaned at 4 weeks of
age and randomly assigned to the sedentary or exercise group. Exercised rats (10 male
and 10 female) were housed individually with a 12-inch diameter stainless steel
exercise wheel, with an attached wheel counter, to monitor wheel revolutions to
determine the voluntary running distance. Sedentary rats (10 male and 10 female rats)
were housed individually without running wheels. Due to endemic respiratory disease in
the rat colony, all study rats were treated with oral antibiotics (trimethoprim-sulfa @ 50
mg/kg/day Trimethoprim and 250 mg/kg/day sulfa) to prevent lung diseases. Antibiotics
were mixed with water for 10 days after assigned into groups. SHR-ex female and SHRex male rats were allowed to exercise for at least 8 weeks before the acute study. The
number of wheel revolutions was recorded twice weekly and converted to a weekly
running distance in kilometers.

Surgical Setup:
Rats were weighed, then placed in an anesthetic chamber, and anesthetized with
isoflurane gas (3%) in oxygen. Once asleep, rats were dosed with Inactin (100mg/kg)
and allowed 10-15 minutes for the Inactin to take effect. Rats were monitored under
anesthesia to avoid breathing difficulties, cardiac depression, or insufficient anesthesia.
The rat’s ventral neck and abdomen, and medial region of each thigh were shaved
using an electric clipper. Rats were then placed on a heating pad and a rectal
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temperature probe was inserted. Rectal temperature was monitored and kept at 36ºC by
adjusting the heating pad and using a heat lamp (on and off) when necessary. An
incision was made in the ventral surface of the neck and a polyethylene tube was
inserted into the trachea (PE 240) to assist with respiration. A saline and heparin (0.3 ml
heparin-1000U/ml in 40ml saline solution) filled catheter (PE 50 attached to an adapter
and a 3 way-stopcock) was inserted and tied into the isolated carotid artery. A pressure
transducer in the catheter was connected to a computer for the measurement of blood
pressure. A saline filled catheter was inserted into the isolated jugular vein and
connected to an infusion pump, which infused saline (20ml/kg/hour) to maintain body
fluid balance. Next, an incision was made on the medial surface of the right thigh. The
femoral artery was isolated, a heparin-saline filled catheter inserted (PE 20), tied in
place, and a pressure transducer in the catheter was connected to the computer for
measurement of renal perfusion pressure (RPP) during the low-pressure periods.
A ventral midline incision was made in the abdomen and the intestines were moved to
one side and wrapped in plastic wrap to keep them moist. The mesenteric and celiac
arteries were isolated using gentle blunt dissection with cotton swabs and forceps, and
a suture was looped around each artery as it exits the aorta. The suture ends were
pulled through a small piece of tubing (PE 190). Tightening the suture ends closed off
these arteries to raise the renal perfusion pressure (RPP). The aorta was isolated
cranial to the renal arteries and caudal to the renal arteries, for later manipulation of
RPP via aortic constriction.
The bladder was isolated, a small cut was made in the cranial edge, and a lipped
urinary catheter (PE 240) was inserted and tied in place for urine collection. The screw
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on the clamp was tightened or loosened to constrict or dilate the forceps to adjust RPP
in a finely controlled manner. Next, the exposed tissue was covered with salinemoistened gauze, and the rat was allowed to equilibrate (rest) for 45 minutes. BP
recordings were collected briefly, every 10-15 minutes during this period to monitor
catheter viability and blood pressure. Starting surgery time, starting and ending saline
infusion time, and saline infusion volume were recorded to ensure similar conditions for
all rats.

Data collection
After equilibration, blood pressure and heart rate were monitored continuously for the
remainder of the study, via the carotid artery and femoral artery catheters, using
computer-connected data collection hardware (Biopac). For every 15 minutes, urine
was aspirated from the bladder catheter and bladder using a tuberculin 1ml (TB) syringe
with an attached PE 50 tube. Urine was placed into a TB syringe, measured, and
covered with parafilm. Samples were stored at 10 degrees C until analysis by flame
photometer. All urine collected between collection periods, when RPP was being
adjusted, was discarded. To determine the baseline values of blood pressure and urine
sodium excretion, two fifteen-minute recordings with corresponding urine samples were
taken. Baseline blood pressure was averaged for the two periods. Then, the aortic
clamp (forceps) was tightened (cranial to the renal arteries) until the blood pressure at
the kidneys ( RPP) was 20 mmHg below the baseline mean, as measured by the
femoral catheter. Urine was collected over two additional 15-minute periods (low RPP).
Next, the aortic clamp was released and the sutures around the celiac and mesenteric
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arteries were tightened to increase blood pressure above the baseline mean by 30
mmHg, measured via the carotid catheter. The aortic clamp was moved to a location
caudal to the renal arteries. The tension on the mesenteric suture and/or the aortic
clamp was adjusted as needed to maintain the desired elevation in RPP. Urine was
collected during three additional 15-minute periods (A third period was added due to a
longer adjustment time in urinary Na+ excretion observed when RPP was raised, than
when lowered. At the end of the acute study, a blood sample was drawn from the lower
aorta using a TB syringe, and hematocrit was measured to check for appropriate
hydration. Anesthetized rats were killed by the creation of a pneumothorax. The kidneys
were removed and weighed.
.

Urine Analysis
Parafilm-sealed urine samples were placed in a refrigerator until later analysis. Urine
samples less than 0.20 ml were diluted to 0.30 ml using double deionized (DDI) water to
ensure adequate volume for analysis. Those volumes of 0.20 ml or greater were diluted
to a volume twice the original to be certain the sodium concentration did not exceed the
recommended upper limit of the flame photometer. To meet the requirements of the
flame photometer, each diluted original urine sample was diluted a second time, 1:200
with DDI water, using an automated diluter. Two of these dilutions were made for each
urine sample, assuring sodium measurement in duplicate for each urine collection
period. Following the standard operating procedure, the flame photometer was
calibrated using a standard 140 mmol/L Na+ solution, diluted 1:200 with DDI water.
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Deionized water was aspirated to set the zero. Once the Na+ ion concentration was
determined, the two samples for each period were averaged, unless the two differed by
more than 5%. In this case, the original urine was reanalyzed. Overall, there were 14
urine samples analyzed for each rat (a duplicate per each collection period). The
sodium excretion was calculated for each rat and period by multiplying the sodium
concentration by the urine volume after the first dilution. Group averages were
calculated for each urine collection period.

Data Analysis
The urine sodium content was measured using a flame photometer. Total sodium
excretion was calculated for each of the samples by multiplying sodium concentration
by the urine volume. For each rat group, urine sodium excretions ug/kg body weight/15
minutes were plotted against the mean arterial pressure. A pressure natriuresis curve
was created by inserting a best-fit regression line for each group. Differences between
groups were determined by parallel line comparison or comparison of the y-intercepts.
Heart rate and RPP data were measured using the Biopac software, and group means
were calculated, for each 15 minutes period. Wheel revolutions were converted into km
and weekly means for males and females were plotted against weeks. Running
distances, RPP, initial urine volumes, and urine sodium excretion were compared using
a two-way ANOVA with repeated measures. We have used equality variance test and
normality test to identify the equality in the variance. Results are express as a mean +/standard error. (Outliers were identified by values two standard deviations from the
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mean, confirmed using a Grubbs test, and removed from the data). Two sedentary
males, one exercise male, and one sedentary female were removed

Results

General data
Table 1 contains the general data for sedentary and exercised SHRs. Hypertensive
sedentary and exercise rats of the same sex did not differ in age, length of time of the
acute study, saline flow rate, hematocrit percentage, kidney weights or body weights.
Male SHR kidney weights and body weights were greater than the female rats (Oneway Anova, p < 0.05)(Table 1).

Running Distance
Both male and female rats increased running distances from week 1 to week 4,
however, the female rats ran an overall greater mean distance than the males (Figure
1). Female rats ran greater distances than the male rats during individual weeks 4 and 6
(Anova, p< 0.05)(figure 1).

Renal Perfusion Pressure
Baseline, lowered and raised RPP values were similar among the groups, (Figure 2)
(Male SHR, ANOVA, df=18, Fstat=1.523, P value=0.233),( Female SHR, ANOVA,
df=17, F stat=0.0213, P value=0.886). The change in RPP (∆RPP) from baseline, for all
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raised and lowered RPP values, was also not different among the groups (Figure 3).
( ANOVA, df=35, Fstat=0.187, P value=0.904.)

Urine Volume
In the sedentary groups and the exercise males, urine volume was increased over the
baseline periods during all high periods. In the exercise female group, only high 2 and
high 3 urine volumes were greater than baseline values. There was no difference
between treatment groups of the same sex (Figure 4).( ANOVA, df=35, Fstat=1.866, P
value=0.153).

Urine Na excretion
Exercised males increased urine sodium excretion over baseline during all high periods.
Sedentary males had a greater urinary Na excretion than baseline in the high 2 and
high3 periods. In the exercise females, urine Na excretion was increased in all high
periods when compared to baseline values. Sodium excretion in the sedentary females
increased over baseline in only the high 2 and high 3 periods. There was no difference
in Na+ excretion among the four groups, and no differences were observed between
treatment groups of same sex (Figure 5).(Male SHR, ANOVA, df=18, Fstat=1.280, P
value=0.273), (Female SHR, ANOVA, df=17, F stat=0.957, P value=0.342).
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Pressure Natriuresis Curves
Pressure Natriuresis -Male: Exercise had no significant effect on the pressure
natriuresis curve in male rats. There was no statistical difference between the slope, or
the Y-Intercept of the pressure natriuresis curve of the exercise males when compared
to sedentary males (Figure 6).( Parallel line Analysis, F stat=0.046, P value=0.8306)
Test for equality of Intercepts, F stat=2.5155, P value=0.1150).
Pressure Natriuresis-Female: Exercise had a significant effect on the pressure
natriuresis curve in female rats. The slope of the curve was greater in the exercised
female rats than in the sedentary female rats (Figure 7).(Parallel line Analysis, F stat
=10.3305, P=0.0017).

Pressure Natriuresis-All Groups
A sex difference was observed in the pressure natriuresis curves when like treated
males and female rats were compared. Parallel line comparison and y intercept
methods used to compare slope differences The slope of sedentary males was
significantly steeper than the sedentary females, and the Y-intercept of exercise males
was significantly more negative than that of the exercise females (Figure 8). (Exercise
males and exercise female - Parallel line analysis, F stat=1.0202, P value=0.3142,
Equality of Intercept , F stat=11.5769, P value=0.0009). (Sedentary male and sedentary
female - Parallel line analysis, F stat=12.2415, P value=0.0006).

23

Discussion
The major finding of this study was the difference in the pressure natriuresis curve of
exercised female rats when compared to sedentary females. Exercise females had an
improved pressure natriuresis response, indicated by the steeper slope of the curve
(Figure 7). This results in a greater increase in urine Na+ excretion for any given
increase in RPP. However, exercise males had no significant pressure natriuresis
changes. The general data of this investigation, summarized in table 1, show no
differences between the groups, except that the males were heavier, and had greater
kidney weights than the female rats. Similar hematocrit percentages and saline infusion
rates indicate similar levels of hydration among the groups, and thus cannot explain the
lack of exercise effect in the male rats.
There were no differences between renal perfusion pressure (RPP), or change in RPP
from baseline, during any manipulation periods in sedentary and exercised rats (Figures
2 and 3), indicating the RPP values and manipulations do not explain the change in the
pressure natriuresis slope. Urine volumes and raw sodium excretion amounts were
elevated above baseline values in all rats when RPP was raised, confirming that a
pressure natriuresis response was stimulated. Urine volume and sodium excretion was
not different within the same sex, however, when RPP was raised, males had larger
urine volume than females undergoing the same treatment, perhaps due to the larger
size and blood volume. The effect of exercise was only evident when urinary sodium
excretion was plotted against RPP, indicating the relationship between sodium excretion
and RPP was altered.
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Between sex, differences were noted when pressure natriuresis curves were compared
between like treatment groups. Sedentary males had a steeper slope than females,
and exercised males had a more negative Y-intercept than exercised females. These
results suggest a more sensitive pressure natriuresis relationship in the male SHR than
in the female. It is unclear if the differences in pressure natriuresis in the sedentary
males versus the females played a role in the lack of effect of exercise in the male SHR.
Another potential explanation for a lack of exercise effect in the males is the lower
running distances of the male rats, particularly noticeable during the earlier weeks when
hypertension would be developing. The enhanced exercise performance of females
compared with males, along with the difference in exercise effects, suggests that sex
/gender difference in exercise performance may influence long-term pressure
regulation. Previous studies in this laboratory showed that WKY females also had
enhanced running performance compared to male WKY rats, but the difference in
running distances was smaller. Other studies have also shown that female rats had
enhanced running performance over male rats (45, 41). A sex difference in the effect of
hypertension on renal functions/glomerular filtration rates, or endothelial function could
modify the effects of exercise. Researchers have determined sexually dimorphic
characteristics to voluntary cage-wheel exercise in rats. Some cardiac morphological
differences such as cardiac mass was significantly greater in female rats compared to
males (45). The same study showed that females had a significantly greater increase in
heart mass for every hour of activity than the male rats (45).
Prior studies in Dr. Knoblich’s laboratory on normotensive WKY rats found that exercise
improved pressure natriuresis in both males and females, and lowered baseline blood
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pressure in anesthetized male, but not female WKY rats (Effects of voluntary exercise
on pressure natriuresis in WKY rats). In the WKY, exercise improved the slope of the
pressure natriuresis curve in both female and male rats when compared to sedentary
groups. Some sex differences were found when comparing treatments between the
sexes in WKY rats. Sedentary females had a more negative Y-intercept than sedentary
males, and exercised females had a steeper slope than exercised males. When
compared to the WKY rats, the sex differences in the pressure-natriuresis curves of the
SHR in the current study were reversed, with the sedentary males showing a greater
slope than females, and exercise males having a more negative Y-intercept than
females. The difference in exercise effects in the SHR, when compared to the WKY,
may be the result of physiological alterations due to hypertension.
The mechanism by which exercise improved pressure natriuresis is unclear. Running
and swimming appear to improve endothelial function (74,6). After 8 weeks of training,
the dilation of the brachial artery when blood flow increases (flow-mediated dilation or
FMD) was changed. However, there was no difference in the response between males
and females (6). NO release from the endothelial cell is one of the main causes of FMD.
Endothelial dysfunction is often found in hypertensive patients. Endothelial dysfunction
can cause abnormalities in vessel walls including renal arteries, and this dysfunction is
linked to many renal diseases including renal fibrosis, which is prevalent in hypertensive
individuals (74,6). The production of nitric oxide by healthy endothelium is believed to
be a key factor in the pressure natriuresis response. Continuous development of renal
medullary oxidative stress causes kidney dysfunctions (54). NO may play a major role in
Na+ excretion and in modulating the pressure natriuresis response in hypertensive rats,
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which have lower levels of NO (54). One study found that continuous NO production
was required to prevent the development of cardiovascular diseases like hypertension
because NO can stimulate renal blood flow. Inhibition of NO production results in
reduced renal medullary blood flow (54). NO acts as a signal to reduce tubular sodium
reabsorption which increases Na+ excretion in normotensive rats. The authors
concluded that reduced renal blood flow influences sodium excretion in hypertensive
rats (54). These findings suggest that NO plays a major role in maintaining pressure
natriuresis, and improvements in endothelial function with exercise could increase NO
synthesis and pressure natriuresis.
Exercise can have beneficial effects on other aspects of kidney function. Glomerular
blood flow regulation and glomerular filtration rate/ capacity are the main factors
associated with body fluid regulation, and these are negatively impacted by
hypertension (11,74). Juxtamedullary nephrons of normotensive rats tend to remain
healthy, however, in SHR, the juxtamedullary complex is complicated and has an
increased risk of pathological lesions such as fibrinoid necrosis, fibro sclerosis, and
glomerulosclerosis (11,74). Moreover, filtration is not normal in the cortical nephrons of
the SHR (74). In contrast to normotensive rats, the renal medulla can be damaged
under hypertensive conditions. Experiments in animal models have shown the benefits
of exercise for kidney disease associated with CVD. Renal inflammation kidney
diseases always follow cardiovascular diseases. Glomerulosclerosis was reduced in
swim exercised rats when compared to sedentary rats. Glomerular filtration rates were
increased in female and male exercised groups compared to sedentary groups (74).
Another study found that the systolic blood pressure and renal fibrosis in hypertensive
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rats improved after exercise training (36). Moreover, exercise groups had a decrease in
inflammatory protein levels, fibrotic-related protein levels, and connecting tissue growth
factors (36, 74). These factors are a major part of renal diseases which can affect the
kidney filtration capacity and glomerular filtration rate in hypertensive rats. Like our SHR
kidney weights, there was no difference in kidney weights between groups in a study
conduct by C. Huang. However, this study histologically analyzed the kidneys and found
SHR had enlarged areas of fibrosis when compared with WKY groups. SHR-exercised
rats had a significant decrease in renal fibrosis (36).
Sex differences in the effects of hypertension produce different outcomes in males and
females. Hypertensive males experience more oxidative stress than hypertensive
females, and males also experience abnormal pressure natriuresis due to high oxidative
stress (70). Researchers examined the influence of sex hormones on renal oxidative
stress in hypertension because oxidative stress due to reactive oxygen species plays an
important role in renal pressure natriuresis. Reactive oxygen species such as hydrogen
peroxide can result in abnormal Na+ handling, and Na+ excretion in hypertensive
individuals by reducing renal blood flow (70). Research conducted by J Sullivan et al
found that male SHRs have increased urinary H2O2 excretion compared to females
(70). Estrogen suppresses reactive oxygen species, and testosterone stimulates
reactive oxygen species, leading to sexual dimorphism in hypertensive rats (70).
Young women have estrogen receptors in many tissues and cells, including vessels,
muscles, endothelial cells, and myocardial cells, while premenopausal women have
fewer estrogen receptors in the same tissues (66). Some population-based studies
demonstrated that postmenopausal women have a high risk of getting cardiovascular
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diseases. The authors suggest that postmenopausal women who carry ESR1 ( estrogen
receptor) have an increased risk of myocardial infarction and other CVD (66). Exercise
and estrogen also maintain normal myosin patterns in slow and fast muscle (41).
Female sex hormones have a strong effect on cardiovascular functions and
musculoskeletal functions (41).
Hypertensive patients often have elevated levels of vasoconstrictive agents, such as
vasopressin, and angiotensin II (54). Vasoconstrictor hormones such as angiotensin,
increase Na+ reabsorption in hypertensive rats. Furthermore, many studies involve the
renin-angiotensin-aldosterone system (RAAS) in hypertensive rats because the RAAS
is the other long-term regulator of blood pressure that is involved with hormones.
Female sex hormones and estrogen receptors in endothelial cells can regulate this
RAAS activity. A study by Nickenig et al demonstrated that Ang II caused significantly
stronger vasoconstriction in ovariectomized rats, supporting the idea that there is a
strong correlation between sex hormones and the RAAS (52). Female sex hormones
have protective cardiovascular effects and estrogen therapies have been used to
prevent CVD. Estrogen therapy reduces the risk of coronary heart disease because it
can reduce coronary artery angiotensin (angiotensin-converting enzyme) activity (71).
Estrogen therapy also increases cardiac atrial natriuretic peptide (ANP) in circulating
blood which acts as a vasodilator and promotes natriuresis (65).
The male sex hormone testosterone also contributes to sex differences in SHRs.
Studies by Jane et al showed that testosterone increases the risk of hypertension in
male SHR via the RAAS (64). Plasma renin concentration is high in males compared to
females (67). Renin converts angiotensinogen to angiotensin I, which subsequently gets
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converted to angiotensin II. Ovariectomized female rodents treated with testosterone
had similar serum testosterone levels and blood pressure levels compared to males
(64).

Conclusion
Our hypothesis was partially correct. Our results support the idea that exercise, as a
non-pharmacological treatment, improves the pressure natriuresis response in female
hypertensive rats. In males, the natriuresis response was not improved, possibly due to
sex differences in the effects of exercise, other physiological factors, or differences in
running distances. It is unclear if greater running distances early in hypertension
development would result in similar effects in the males. Because hypertension results
in endothelial dysfunction and progressive renal damage, it is not surprising that some
of the benefits of exercise on hypertension may be within the kidneys. The exact
mechanism by which pressure natriuresis was altered in the exercised rats is unclear,
but improved endothelial function and nitric oxide production, resulting in less renal
fibrosis, and improved renal function, remains a possibility. Identifying the specific
mechanisms could support the development of therapeutic strategies for hypertension
that focus on pressure natriuresis.
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Future Studies
The exact mechanism and mediators behind the alterations in pressure natriuresis
should be determined. Further examination of gender differences associated with
pressure natriuresis, and the effects of sex hormones combined with exercise on
pressure natriuresis in female and male SHR and WKY rats would also be beneficial.
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Table and Figures

Table 1: General data from sedentary and exercise SHRs. Age at the time of the
study, acute study total time, saline infusion rate (flow rate), hematocrit, kidney weight,
and body weight are shown as means ± SE. SHR = spontaneously hypertensive rats
Group

Sedentary

Age

Acute study

Flow rate

(wks)

(hr)

(ml/kg/hr)

16.43 ± 0.90

6.46 ± 0.32

19.05 ± 1.15

17.65 ± 0.74

5.99 ± 0.23

16.91 ± 1.01

16.67 ± 0.46

Hematocrit (%)

Kidney

Body weight

weight (g)

(kg)

67.20 ± 2.59

2.60 ± 0.08*

0.32 ± 0.011*

18.64 ± 0.83

62.10 ± 2.89

2.90 ± 0.05*

0.36 ± 0.011*

5.41 ± 0.25

25.96 ± 1.34

62.67 ± 1.14

1.59 ± 0.03

0.21 ± 0.004

6.12 ± 0.28

22.06 ± 1.06

62.00 ± 3.21

1.85 ± 0.04

0.23 ± 0.004

Male
Exercise
Male
Sedentary
Female
Exercise
Female

* p < 0.05 when compared to the female rats of the same treatment
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Running Distances
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†
Males (n=10)
Females (n=10) †
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†
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Wk 5

Wk 6

Wk 7

Wk 8

Wk 9

Week

Figure 1: Weekly running distances in male and female SHR. Values are mean ± SE. † p <
0.05 when compared to the male rats.
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Renal Perfusion Pressure

Renal Perfusion Pressure
(mmHg)
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Exercise F (n=10)
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Low 1

Low 2

High 1

High 2

High 3

Manipulation Period

Figure 2: Renal perfusion pressure (RPP) during baseline (BL), lowered (low), and raised
(high) manipulations in sedentary and exercised male and females SHR. Values are mean ± SE.
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Change in Renal Perfusion Pressure
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Change in RPP
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Figure 3: Change from baseline in renal perfusion pressure during lowered (low) and raised
(high) manipulations in sedentary and exercised male and female SHR. Values are mean ± SE.
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Urine Volume

Urine Volume
ml/kg/15 minutes

1.5

Sedentary M (n=10)
Exercise M (n=10)
Sedentary F (n=9)
Exercise F (n=10)

*
*

1.0

*
*

*
*
*

*
*
*

*

0.5

0.0

BL 1

BL 2

Low 1

Low 2

High 1

High 2

High 3

Manipulation Period
Figure 4: Mean urine volume during baseline (BL), lowered (low), and raised (high)
manipulations of renal perfusion pressure in sedentary and exercised male and female SHR.
Values are mean ± SE. *P < 0.05 when compared to baseline
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Urine Sodium Excretion
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*

*
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Figure 5: Urine sodium excretion during baseline (BL), lowered (low), and raised (high)
manipulations of renal perfusion pressure in sedentary and exercised male and female SHR.
Values are mean ± SE. *P < 0.05 when compared to baseline.
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Pressure Natriuresis Curves - Males
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Figure 6: Pressure natriuresis curves in sedentary and exercised male SHR. Neither the slope or
the Y-intercept was different between the groups.
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Pressure Natriuresis Curves - Females
400
Sedentary F (n=9)
Sedentary F Natriuresis
Exercise F (n=10)
Exercise F Natriuresis †

Na+ Excretion
(umol/kg/15 min)

300

200

100

0

-100
40

60

80

100

120

140

160

180

200

Renal Perfusion Pressure
(mmHg)
Figure 7: Pressure natriuresis curves in sedentary and exercised female SHR. † P < 0.05 when
compared to the slope of the natriuresis curve of the sedentary rats.
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Pressure Natriuresis Curves
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Figure 8: Pressure natriuresis curves in sedentary and exercised, male and female SHR.
† P < 0.05 when the slope is compared to that of the female rats of the same treatment.
δ P < 0.05 when the Y-intercept is compared to the female rats of the same treatment.

40

References
1.

Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray
GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, Svetkey LP,
Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller
ER, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative
Research Group. Effects on blood pressure of reduced dietary sodium and the
Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium
Collaborative Research Group. N Engl J Med 344: 3–10, 2001. doi:
10.1056/NEJM199704173361601.

2.

Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, Basora J.
Physical activity, cardiovascular health, quality of life and blood pressure control
in hypertensive subjects: Randomized clinical trial 11 Medical and Health
Sciences 1117 Public Health and Health Services 11 Medical and Health
Sciences 1102 Cardiorespir. Health Qual Life Outcomes 16, 2018. doi:
10.1186/s12955-018-1008-6.

3.

Armstrong C, Senior AFP, Editor A. Practice Guidelines JNC 8 Guidelines for
the Management of Hypertension. [Online]. www.aafp.org/afp.

4.

August P. Hypertension in men. J Clin Endocrinol Metab 84: 3451–3454, 1999.
doi: 10.1210/jcem.84.10.6124.

5.

August P. Hypertension in men. J Clin Endocrinol Metab 84: 3451–3454, 1999.
doi: 10.1210/jcem.84.10.6124.

6.

Beck DT, Casey DP, Martin JS, Emerson BD, Braith RW. Exercise training
improves endothelial function in young prehypertensives. Exp Biol Med 238: 433–

41

441, 2013. doi: 10.1177/1535370213477600.
7.

Beck DT, Martin JS, Casey DP, Braith RW. Exercise training reduces peripheral
arterial stiffness and myocardial oxygen demand in young prehypertensive
subjects. Am J Hypertens 26: 1093–1102, 2013. doi: 10.1093/ajh/hpt080.

8.

Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: New roles in
inflammation, immunology and aging. EMBO Mol Med 2: 247–257, 2010. doi:
10.1002/emmm.201000080.

9.

Bethany E, Zajacova Anna. Gender differences in hypertension among young
adults. HHS Public Access 61: 1–17, 2016. doi:
10.1080/19485565.2014.929488.Gender.

10.

Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic
diseases. Compr Physiol 2: 1143–1211, 2012. doi: 10.1002/cphy.c110025.

11.

Breiding MJ. 肌肉作为内分泌和旁分泌器官 HHS Public Access. Physiol Behav
63: 1–18, 2014. doi: 10.1161/HYPERTENSIONAHA.118.11176.Klotho.

12.

Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E,
Ernst ND, Horan M. Body mass index and the prevalence of hypertension and
dyslipidemia. Obes Res 8: 605–619, 2000. doi: 10.1038/oby.2000.79.

13.

Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ,
Labarthe D. Prevalence of Hypertension in the US Adult Population.
Hypertension 25: 305–313, 1995. doi: 10.1161/01.hyp.25.3.305.

14.

Carey RM, Calhoun DA, Vice F, George L, Brook RD, Daugherty SL, Cheryl
R, Egan BM, Flack JM. HHS Public Access. 2019.

15.

Carey RM, Padia SH. Role of angiotensin AT2 receptors in natriuresis: Intrarenal

42

mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol 40: 527–534,
2013. doi: 10.1111/1440-1681.12059.
16.

Castrop H, Höcherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology
of kidney renin. Physiol Rev 90: 607–673, 2010. doi:
10.1152/physrev.00011.2009.

17.

Chew BH, Ismail M, Lee PY, Taher SW, Haniff J, Mustapha FI, Bujang MA.
Determinants of uncontrolled dyslipidaemia among adult type 2 diabetes in
Malaysia: The Malaysian Diabetes Registry 2009. Diabetes Res Clin Pract 96:
339–347, 2012. doi: 10.1016/j.diabres.2012.01.017.

18.

Choi HM, Kim HC, Kang DR. Sex differences in hypertension prevalence and
control: Analysis of the 2010-2014 Korea national health and nutrition examination
survey. PLoS One 12: 1–12, 2017. doi: 10.1371/journal.pone.0178334.

19.

Coimbra R, Sanchez LS, Potenza JM, Rossoni L V., Amaral SL, Michelini LC.
Is gender crucial for cardiovascular adjustments induced by exercise training in
female spontaneously hypertensive rats? Hypertension 52: 514–521, 2008. doi:
10.1161/HYPERTENSIONAHA.108.114744.

20.

Collier SR, Sandberg K, Moody AM, Frechette V, Curry CD, Ji H, Gowdar R,
Chaudhuri D, Meucci M. Reduction of plasma aldosterone and arterial stiffness
in obese pre- and stage1 hypertensive subjects after aerobic exercise. J Hum
Hypertens 29: 53–57, 2015. doi: 10.1038/jhh.2014.33.

21.

Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in
hypertension prevalence, awareness, treatment, and control rates in United
States adults between 1988-1994 and 1999-2004. Hypertension 52: 818–827,

43

2008. doi: 10.1161/HYPERTENSIONAHA.108.113357.
22.

DeMers D, Wachs D. Physiology, Mean Arterial Pressure [Online].
http://www.ncbi.nlm.nih.gov/pubmed/30855814 [27 Oct. 2019].

23.

Drawz P, Ghazi L. Advances in understanding the renin-angiotensin-aldosterone
system (RAAS) in blood pressure control and recent pivotal trials of RAAS
blockade in heart failure and diabetic nephropathy. F1000Research 6: 1–10,
2017. doi: 10.12688/f1000research.9692.1.

24.

Ely DL, Turner ME. Hypertension in the spontaneously hypertensive rat is linked
to the Y chromosome. Hypertension 16: 277–281, 1990. doi:
10.1161/01.HYP.16.3.277.

25.

Engberink RHGO, Frenkel WJ, Van Den Bogaard B, Brewster LM, Vogt L,
Van Den Born BJH. Effects of thiazide-type and thiazide-like diuretics on
cardiovascular events and mortality: Systematic review and meta-analysis.
Hypertension 65: 1033–1040, 2015. doi:
10.1161/HYPERTENSIONAHA.114.05122.

26.

Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman
MB, Bergus GR. Comparative antihypertensive effects of hydrochlorothiazide
and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:
352–358, 2006. doi: 10.1161/01.HYP.0000203309.07140.d3.

27.

Fiedler F, Luke S, Gerzer R. Evidence that Urodilatin, Sodium Excretion. .

28.

Figueiredo T, Rhea MR, Peterson M, Miranda H, Bentes CM, dos Reis VM de
R, Simão R. Influence of number of sets on blood pressure and heart rate
variability after a strength training session. J strength Cond Res 29: 1556–63,

44

2015. doi: 10.1519/JSC.0000000000000774.
29.

Fitchett D. Results of the ONTARGET and TRANSCEND studies: An update and
discussion. Vasc Health Risk Manag 5: 21–29, 2009. doi: 10.2147/vhrm.s3718.

30.

Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB,
Levy D. Hemodynamic patterns of age-related changes in blood pressure. The
Framingham Heart Study. Circulation 96: 308–315, 1997. doi:
10.1161/01.cir.96.1.308.

31.

Gerzer; R.; Drummer; C. Is_the_Renal_Natriuretic_Peptide_Urodilatin.28 (1).pdf
[Online]. [date unknown].
https://journals.lww.com/cardiovascularpharm/Abstract/1993/22002/Is_the_Renal
_Natriuretic_Peptide_Urodilatin.28.aspx.

32.

Haapanen N, Miilunpalo S, Vuori I, Oja P, Pasanen M. Association of leisure
time physical activity with the risk of coronary heart disease, hypertension and
diabetes in middle-aged men and women. Int J Epidemiol 26: 739–747, 1997. doi:
10.1093/ije/26.4.739.

33.

Hinojosa-Laborde C, Chapa I, Lange D, Haywood J. Experimental Biology
1998 Symposium on Sex Steroids in Cardiovascular – Renal Physiology and
Pathophysiology GENDER DIFFERENCES IN SYMPATHETIC NERVOUS
SYSTEM REGULATION. : 127–131, 1999.

34.

Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P.
Relationship of Physical Activity and Body Mass Index to the Risk of
Hypertension: A Prospective Study in Finland. Hypertension 43: 25–30, 2004. doi:
10.1161/01.HYP.0000107400.72456.19.

45

35.

Huang CC, Lin YY, Yang AL, Kuo TW, Kuo CH, Lee S Da. Anti-renal fibrotic
effect of exercise training in hypertension. Int J Mol Sci 19, 2018. doi:
10.3390/ijms19020613.

36.

Huang CC, Lin YY, Yang AL, Kuo TW, Kuo CH, Lee S Da. Anti-renal fibrotic
effect of exercise training in hypertension. Int J Mol Sci 19, 2018. doi:
10.3390/ijms19020613.

37.

Jh F, Sl L. Physiology , Renin Angiotensin System Organ Systems Involved
Continuing Education / Review Questions Publication Details Author Information. .

38.

Jonathan Posner and Bradley S. Peterson JAR. 基因的改变NIH Public
Access. Bone 23: 1–7, 2008. doi:
10.1161/01.HYP.0000056768.03657.B4.Enhancement.

39.

Jordan J, Birkenfeld AL, Melander O, Moro C. Natriuretic peptides in
cardiovascular and metabolic crosstalk implications for hypertension
management. Hypertension 72: 270–276, 2018. doi:
10.1161/HYPERTENSIONAHA.118.11081.

40.

Jurik, Stastny. Role of Nutrition and Exercise Programs in Reducing Blood
Pressure: A Systematic Review. J Clin Med 8: 1393, 2019. doi:
10.3390/jcm8091393.

41.

Kadi F, Karlsson C, Larsson B, Eriksson J, Larval M, Billig H, Jonsdottir IH.
The effects of physical activity and estrogen treatment on rat fast and slow
skeletal muscles following ovariectomy. J Muscle Res Cell Motil 23: 335–339,
2002. doi: 10.1023/A:1022071114344.

42.

Khan N, McAlister FA. Re-examining the efficacy of β-blockers for the treatment

46

of hypertension: A meta-analysis. Cmaj 174: 1737–1742, 2006. doi:
10.1503/cmaj.060110.
43.

Koh KK, Quon MJ. Targeting converging therapeutic pathways to overcome
hypertension. Int J Cardiol 132: 297–299, 2009. doi: 10.1016/j.ijcard.2008.11.150.

44.

Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Koh Y, Shin EK. Distinct vascular
and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol
140: 73–81, 2010. doi: 10.1016/j.ijcard.2008.11.017.

45.

Konhilas JP, Maass AH, Luckey SW, Stauffer BL, Olson EN, Leinwand LA.
Sex modifies exercise and cardiac adaptation in mice. Am J Physiol - Hear Circ
Physiol 287, 2004. doi: 10.1152/ajpheart.00292.2004.

46.

Lee SH, Hwang SM, Kang DH, Yang HJ. Brain education-based meditation for
patients with hypertension and/or type 2 diabetes: A pilot randomized controlled
trial. Medicine (Baltimore) 98: e15574, 2019. doi:
10.1097/MD.0000000000015574.

47.

Lee SH, Hwang SM, Kang DH, Yang HJ. Brain education-based meditation for
patients with hypertension and/or type 2 diabetes: A pilot randomized controlled
trial. Medicine (Baltimore) 98: e15574, 2019. doi:
10.1097/MD.0000000000015574.

48.

Lidfeldt J, Lanke J, Sundquist J, Lindholm LH. Old patients with hypertension.
A 25-year observational study of a geographically defined population (Dalby),
aged 67 years at entry. J Intern Med 244: 469–478, 1998. doi: 10.1046/j.13652796.1998.00391.x.

49.

Maki KC, Galant R, Samuel P, Tesser J, Witchger MS, Ribaya-Mercado JD,

47

Blumberg JB, Geohas J. Effects of consuming foods containing oat β-glucan on
blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in
men and women with elevated blood pressure. Eur J Clin Nutr 61: 786–795,
2007. doi: 10.1038/sj.ejcn.1602562.
50.

Missud DC, Parot-Schinkel E, Connan L, Vielle B, Huez JF. Physical activity
prescription for general practice patients with cardiovascular risk factors-the
PEPPER randomised controlled trial protocol. BMC Public Health 19, 2019. doi:
10.1186/s12889-019-7048-y.

51.

Nawrot T, Den Hond E, Thijs L, Staessen JA. Blood pressure and aging. .

52.

Nickenig G, Ba AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Sta A,
Beckers F. Estrogen Modulates AT 1 Receptor Gene Expression [Online].
https://pdfs.semanticscholar.org/1671/767f77ed9735809d39c60e1d7d138da624a
2.pdf.

53.

Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in
cardioprotection. Cardiovasc Res 69: 318–328, 2006. doi:
10.1016/j.cardiores.2005.10.001.

54.

O’Connor PM, Cowley AW. Modulation of pressure-natriuresis by renal
medullary reactive oxygen species and nitric oxide. Curr. Hypertens. Rep. 12: 86–
92, 2010.

55.

Oguchi H, Sasamura H, Shinoda K, Morita S, Kono H, Nakagawa K, Ishiguro
K, Hayashi K, Nakamura M, Azegami T, Oya M, Itoh H. Renal arteriolar injury
by salt intake contributes to salt memory for the development of hypertension.
Hypertension 64: 784–791, 2014. doi: 10.1161/HYPERTENSIONAHA.113.02973.

48

56.

Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence
Among Adults Aged 18 and Over: United States, 2017-2018. NCHS Data Brief :
1–8, 2020.

57.

Oster JR, Materson BJ, Perez-Stable E. Antihypertensive medications. South
Med J 77: 621–630, 1984. doi: 10.1097/00007611-198405000-00020.

58.

Padia SH, Howell NL, Siragy HM, Carey RM. Renal angiotensin type 2
receptors mediate natriuresis via angiotensin III in the angiotensin II type 1
receptor-blocked rat. Hypertension 47: 537–544, 2006. doi:
10.1161/01.HYP.0000196950.48596.21.

59.

Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA.
Exercise and Hypertension. Med Sci Sport Exerc 36: 533–553, 2004. doi:
10.1249/01.MSS.0000115224.88514.3A.

60.

Pinto E. Blood pressure and ageing. Postgrad Med J 83: 109–114, 2007. doi:
10.1136/pgmj.2006.048371.

61.

Potter LR. Natriuretic peptide metabolism, clearance and degradation. FEBS J
278: 1808–1817, 2011. doi: 10.1111/j.1742-4658.2011.08082.x.

62.

Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides:
Their structures, receptors, physiologic functions and therapeutic applications.
Handb Exp Pharmacol 191: 341–366, 2009. doi: 10.1007/978-3-540-68964-5_15.

63.

Rader DJ. Human genetics of atherothrombotic disease and its risk factors.
Arterioscler Thromb Vasc Biol 35: 741–747, 2015. doi:
10.1161/ATVBAHA.115.305492.

64.

Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of

49

hypertension in spontaneously hypertensive rats: Role of the renin-angiotensin
system. Hypertension 35: 480–483, 2000. doi: 10.1161/01.hyp.35.1.480.
65.

Sankaralingam A. Increase in circulating levels of cardiac natriuretic peptides
after hormone replacement therapy in postmenopausal women (S Maffei, S Del
Ry, C Clerico. Clin Scie 2001; 101: 447-53). CPD Bull Clin Biochem 4: 81, 2002.

66.

Schuit SCE, Oei HHS, Witteman JCM, Van Kessel CHG, Van Meurs JBJ,
Nijhuis RL, Van Leeuwen JPTM, De Jong FH, Zillikens MC, Hofman A, Pols
HAP, Uitterlinden AG. Estrogen receptor α gene polymorphisms and risk of
myocardial infarction. J Am Med Assoc 291: 2969–2977, 2004. doi:
10.1001/jama.291.24.2969.

67.

Silva-Antonialli MM, Tostes RCA, Fernandes L, Fior-Chadi DR, Akamine EH,
Carvalho MHC, Fortes ZB, Nigro D. A lower ratio of AT1/AT2 receptors of
angiotensin II is found in female than in male spontaneously hypertensive rats.
Cardiovasc Res 62: 587–593, 2004. doi: 10.1016/j.cardiores.2004.01.020.

68.

Smulyart H, Asmar RG, Rudnicki A, London GM, Safar ME. Comparative
effects of aging in men and women on the properties of the arterial tree. J Am Coll
Cardiol 37: 1374–1380, 2001. doi: 10.1016/S0735-1097(01)01166-4.

69.

Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of
diastolic blood pressure when treating isolated systolic hypertension. Arch Intern
Med 159: 2004–2009, 1999. doi: 10.1001/archinte.159.17.2004.

70.

Sullivan JC, Sasser JM, Pollock JS. Sexual dimorphism in oxidant status in
spontaneously hypertensive rats. Am J Physiol - Regul Integr Comp Physiol 292:
764–768, 2007. doi: 10.1152/ajpregu.00322.2006.

50

71.

Tanaka M, Nakaya S, Watanabe M, Kumai T, Tateishi T. Effects of ovariectomy
and estrogen enzyme replacement activity on aorta in rats angiotensin. Jpn J
Pharmacol 73: 361–363, 1997.

72.

Tarkin JM, Dweck MR, Evans NR, Takx RAP, Brown AJ, Tawakol A, Fayad
ZA, Rudd JHF. Imaging Atherosclerosis. Circ Res 118: 750–69, 2016. doi:
10.1161/CIRCRESAHA.115.306247.

73.

Te Riet L, Van Esch JHM, Roks AJM, Van Den Meiracker AH, Danser AHJ.
Hypertension: Renin-Angiotensin-Aldosterone System Alterations. Circ Res 116:
960–975, 2015. doi: 10.1161/CIRCRESAHA.116.303587.

74.

Totou NL, Moura SS, Coelho DB, Oliveira EC, Becker LK, Lima WG.
Swimming exercise demonstrates advantages over running exercise in reducing
proteinuria and glomerulosclerosis in spontaneously hypertensive rats. Physiol.
Int. 105: 76–85, 2018.

75.

Wager MGT and JFS. 基因的改变NIH Public Access. Bone 23: 1–7, 2011. doi:
10.1016/j.bbrc.2011.06.192.Glycosylation.

76.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison
Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW,
MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford
RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for
the Prevention, Detection, Evaluation, and Management of High Blood Pressure
in Adults: A Report of the American College of Cardiology/American Heart
Association Task Force on Clinical Pr. J Am Coll Cardiol 71: e127–e248, 2018.

51

doi: 10.1016/j.jacc.2017.11.006.
77.

Zhang Y, Yu XJ, Chen WS, Gao HL, Liu KL, Shi XL, Fan XY, Jia LL, Cui W,
Zhu GQ, Liu JJ, Kang YM. Exercise training attenuates renovascular
hypertension partly via RAS-ROS-glutamate pathway in the hypothalamic
paraventricular nucleus. Sci Rep 6, 2016. doi: 10.1038/srep37467.

